HERON THERAPEUTICS, INC. /DE/ Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HERON THERAPEUTICS, INC. /DE/ stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $225.00K, a 61.67% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $587.00K, a 235.43% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $175.00K, a 75.14% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $704.00K, a 8.81% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ stock issued during period, value, employee stock purchase plan for fiscal 2025 was $853.00K, a 33.91% increase from fiscal 2024.
- HERON THERAPEUTICS, INC. /DE/ stock issued during period, value, employee stock purchase plan for fiscal 2024 was $637.00K, a 29.54% decline from fiscal 2023.
- HERON THERAPEUTICS, INC. /DE/ stock issued during period, value, employee stock purchase plan for fiscal 2023 was $904.00K, a 37.40% decline from fiscal 2022.
- HERON THERAPEUTICS, INC. /DE/ stock issued during period, value, employee stock purchase plan for fiscal 2022 was $1.44M, a 32.49% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $225.00K 10-Q · filed 2026-08-10 | |
| 2025-12-31 | $853.00K 10-K · filed 2026-02-26 | |
| 2025-06-30 | $587.00K 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $637.00K 10-K · filed 2026-02-26 | |
| 2024-06-30 | $175.00K 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $904.00K 10-K · filed 2026-02-26 | |
| 2023-06-30 | $704.00K 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $1.44M 10-K · filed 2025-02-27 | |
| 2022-06-30 | $772.00K 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $2.14M 10-K · filed 2023-03-29 | |
| 2021-06-30 | $1.53M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $2.32M 10-K · filed 2022-02-28 | |
| 2020-06-30 | $1.51M 10-Q · filed 2021-11-03 | |
| 2019-12-31 | $2.11M 10-K · filed 2022-02-28 | |
| 2019-06-30 | $1.17M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $1.18M 10-K · filed 2021-02-24 | |
| 2018-06-30 | $648.00K 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $989.00K 10-K · filed 2020-03-02 | |
| 2016-12-31 | $771.00K 10-K · filed 2019-02-22 | |
| 2015-12-31 | $257.00K 10-K · filed 2018-02-27 | |
| 2014-12-31 | $91.00K 10-K · filed 2017-02-23 | |
| 2013-12-31 | $34.00K 10-K · filed 2016-02-19 | |
| 2012-12-31 | $22.00K 10-K · filed 2015-03-13 | |
| 2011-12-31 | $15.00K 10-K · filed 2014-03-07 | |
| 2010-12-31 | $30.00K 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |